News Release - July 6, 2007

New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV

Source: Tibotec Therapeutics

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.